- Uniphar said it had acquired Nordic-based medtech service provider EPS and Ireland-based rival M3 Medical for a combined up to €40m.

The acquisition sum would be paid over four years, with a deferred consideration to be linked to operating earnings performance over that period.

'This cluster of acquisitions represent another important development in the roll-out of Uniphar's pan-European growth strategy for its commercial and clinical division,' the company said.

At 8:00am: [LON:UPR] share price was 0p at 1.2p

Story provided by